Skip to content
    Real-World Studies

    p53 Expression in Vulvar Squamous Cell Carcinoma Associated with Inguinal Nodal Metastasis

    Salameh et alBMC Cancer

    A retrospective cohort study evaluated the association between p53 and p16 biomarker expression and clinical outcomes in 125 women with FIGO stage I–IV vulvar squamous cell carcinoma (VSCC) treated at Hôtel-Dieu de France in Beirut, Lebanon, between 2014 and 2024. Among 86 patients who underwent immunohistochemical profiling for p53 and p16, 38 were p53-positive, 15 were p16-positive, 33 were negative for both markers, and 14 were HPV-positive by vaginal PCR.
    Tumor analysis demonstrated that p53 positivity correlated with more aggressive clinicopathologic features. Patients with p53-positive tumors were significantly more likely to present with central tumor locations, necessitating clitoral excision in 100% of cases in this subgroup (p = 0.008). Additionally, p53 expression was associated with higher rates of inguinal lymph node metastasis (p < 0.001), a greater number of excised metastatic lymph nodes (p = 0.001), and worse baseline Eastern Cooperative Oncology Group (ECOG) performance scores (p = 0.04). Although p53-positive tumors demonstrated a trend toward greater depth of invasion, the difference did not reach statistical significance.
    Despite these aggressive pathologic features, p53 status did not impact key oncologic and surgical endpoints: postoperative complication rates, recurrence rates, and overall survival were comparable across biomarker groups. Furthermore, no significant associations were identified between p16 expression, HPV status, or smoking history and clinical outcomes. The authors concluded that while p53 expression reflects heightened clinical aggressiveness and extended surgical resection requirements due to tumor centrality, its utility as an independent prognostic marker for recurrence or survival requires further evaluation in prospective studies.

    Key Takeaways

    • In patients with vulvar squamous cell carcinoma, p53 positivity was significantly associated with increased rates of inguinal lymph node metastasis (p < 0.001) and a higher count of excised metastatic lymph nodes (p = 0.001).
    • Tumors in the p53-positive subgroup were more frequently central, resulting in clitoral excision in all p53-positive patients (p = 0.008), though p53 status was not associated with differences in postoperative complication rates, tumor recurrence, or overall survival.
    • No significant clinical or prognostic associations were observed regarding p16 expression, HPV status, or smoking history in this patient cohort.